BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12516584)

  • 21. Adverse events associated with supplements containing ephedra alkaloids.
    Geiger JD
    Clin J Sport Med; 2002 Jul; 12(4):263. PubMed ID: 12150162
    [No Abstract]   [Full Text] [Related]  

  • 22. Black cohosh, safety, and public awareness.
    Dunbar K; Solga SF
    Liver Int; 2007 Sep; 27(7):1017-8. PubMed ID: 17696943
    [No Abstract]   [Full Text] [Related]  

  • 23. Rethinking natural-born killers.
    Galeotti S
    Nat Med; 2003 Oct; 9(10):1236. PubMed ID: 14520361
    [No Abstract]   [Full Text] [Related]  

  • 24. JAMA patient page. Ephedra and ephedrine.
    Torpy JM; Lynm C; Glass RM
    JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular effects of ephedra.
    Ness J
    JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069037
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular effects of ephedra.
    Krantz MJ
    JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069036
    [No Abstract]   [Full Text] [Related]  

  • 27. "Tag--we're it".
    Czap A
    Altern Med Rev; 2003 May; 8(2):104. PubMed ID: 12777156
    [No Abstract]   [Full Text] [Related]  

  • 28. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to ban ephedra--now.
    Guharoy R; Noviasky JA
    Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759
    [No Abstract]   [Full Text] [Related]  

  • 30. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act.
    Foote JC
    J Allied Health; 2007; 36(1):57-60. PubMed ID: 17425193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Health risks raised by ephedra in food supplements].
    van Riel AJ; de Vries I; Meulenbelt J
    Ned Tijdschr Geneeskd; 2003 Oct; 147(41):2017-9. PubMed ID: 14587144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrocardiographic effects of a dietary supplement containing ephedra and caffeine.
    Milic M; Rizos D; Ziegler MG
    JAMA; 2005 Sep; 294(12):1487; author reply 1487-8. PubMed ID: 16189358
    [No Abstract]   [Full Text] [Related]  

  • 33. [Case of intractable ventricula fibrillation by a multicomponent dietary supplement containing ephedra and caffeine overdose].
    Takeuchi S; Homma M; Inoue J; Kato H; Murata K; Ogasawara T
    Chudoku Kenkyu; 2007 Jul; 20(3):269-71. PubMed ID: 17784561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutraceuticals: miracle or meme?
    Ridinger MH
    Clin Pharmacol Ther; 2007 Oct; 82(4):352-6. PubMed ID: 17851571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dangerous supplements: what you don't know about these 12 ingredients could hurt you.
    Consum Rep; 2010 Sep; 75(9):16-20. PubMed ID: 20712098
    [No Abstract]   [Full Text] [Related]  

  • 36. In brief: Herbal warning.
    Med Lett Drugs Ther; 2008 Feb; 50(1279):9. PubMed ID: 18264032
    [No Abstract]   [Full Text] [Related]  

  • 37. Ergogenic aids: an update on ephedra.
    Keisler BD; Hosey RG
    Curr Sports Med Rep; 2005 Aug; 4(4):231-5. PubMed ID: 16004835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond ephedra. Why the FDA's ban may lead users to look for other weight-loss stimulants.
    Gupta S
    Time; 2004 Jan; 163(2):78. PubMed ID: 14735657
    [No Abstract]   [Full Text] [Related]  

  • 39. Herbal supplements may require modifications of dental treatment.
    Abebe W
    Dent Today; 2009 Jan; 28(1):136-7. PubMed ID: 19323340
    [No Abstract]   [Full Text] [Related]  

  • 40. Ephedra-associated cardiomyopathy.
    Naik SD; Freudenberger RS
    Ann Pharmacother; 2004 Mar; 38(3):400-3. PubMed ID: 14742827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.